Eplerenone in pregnancy
Obstetric Medicine · 24.06.2026
DOI: 10.1177/1753495x261463148 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Obstetric Medicine, online erschienen am 24.06.2026. Verfasst von Adam Morton. Beteiligte Einrichtung: Department of Obstetric Medicine, Mater Hospital Brisbane, South Brisbane, Queensland, Australia. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Eplerenone is a mineralocorticoid receptor antagonist with minimal affinity for androgen receptors. Mineralocorticoid receptor antagonists are efficacious in the management of resistant hypertension, obstructive sleep apnea, cardiac dysfunction, renal tubular disorders, hepatic cirrhosis, portal hypertension, diabetic nephropathy, proteinuric kidney disease, and chronic central serous chorioretinopathy in the general population. Five cases describing the use of eplerenone in pregnancy are discussed, the previous literature reviewed, and potential indications for the use of eplerenone in pregnancy discussed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetric Medicine, Mater Hospital Brisbane, South Brisbane, Queensland, Australia.
- Division of Medicine, University of Queensland, Herston, Brisbane, Queensland, Australia.
ORCID-Profile: Adam Morton
Zitieren
APA
Morton, A. (2026). Eplerenone in pregnancy. Obstetric Medicine. https://doi.org/10.1177/1753495x261463148
Vancouver
Morton A. Eplerenone in pregnancy. Obstetric Medicine. 2026. doi:10.1177/1753495x261463148
BibTeX
@article{Morton2026,
author = {Morton, Adam},
title = {Eplerenone in pregnancy},
journal = {Obstetric Medicine},
year = {2026},
doi = {10.1177/1753495x261463148}
}
EUVIMED